M&G Plc Raises Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

M&G Plc raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.9% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 363,045 shares of the medical instruments supplier’s stock after purchasing an additional 10,382 shares during the period. M&G Plc’s holdings in DENTSPLY SIRONA were worth $9,802,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares in the last quarter. LRI Investments LLC raised its holdings in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new position in DENTSPLY SIRONA in the 2nd quarter worth approximately $32,000. Van ECK Associates Corp acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $42,000. Finally, Allworth Financial LP grew its position in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $17.26 on Friday. The firm has a 50-day simple moving average of $24.82 and a two-hundred day simple moving average of $25.98. The stock has a market cap of $3.50 billion, a PE ratio of -20.07, a P/E/G ratio of 1.27 and a beta of 1.02. DENTSPLY SIRONA Inc. has a 1-year low of $17.22 and a 1-year high of $37.60. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on XRAY. Evercore ISI reduced their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Wednesday. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday. Stifel Nicolaus reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Finally, Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $31.88.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.